Abstract
Lipids, one of the major natural products, usually have high biocompatibility and low toxicity. Due to their proper physicochemical properties, they are the most commonly used materials for building modern drug delivery systems, especially nanocarriers. However, to impart new functions or to satisfy special requirements, the lipids can be modified or synthesized. Using lipids or lipid derivatives, various lipid-based drug or gene delivery systems have been developed and show potential in pre-clinical and clinical applications. In this article, the most commonly used lipids are discussed in terms of their properties and functions as drug carrier components, their chemical modifications, the formulation or composition of lipid-based nanocarriers, and their biomedical applications. This article provides a critical view and possible future directions of lipid-based drug delivery strategies.
Keywords: Drug delivery, gene delivery, lipids, lipid conjugate, lipid derivatives, nanocarrier, natural product.
Current Drug Targets
Title:Lipids and Their Derivatives: By-Products Used as Essential Building Blocks for Modern Drug Delivery Systems
Volume: 15 Issue: 5
Author(s): Ying Tu and Lin Zhu
Affiliation:
Keywords: Drug delivery, gene delivery, lipids, lipid conjugate, lipid derivatives, nanocarrier, natural product.
Abstract: Lipids, one of the major natural products, usually have high biocompatibility and low toxicity. Due to their proper physicochemical properties, they are the most commonly used materials for building modern drug delivery systems, especially nanocarriers. However, to impart new functions or to satisfy special requirements, the lipids can be modified or synthesized. Using lipids or lipid derivatives, various lipid-based drug or gene delivery systems have been developed and show potential in pre-clinical and clinical applications. In this article, the most commonly used lipids are discussed in terms of their properties and functions as drug carrier components, their chemical modifications, the formulation or composition of lipid-based nanocarriers, and their biomedical applications. This article provides a critical view and possible future directions of lipid-based drug delivery strategies.
Export Options
About this article
Cite this article as:
Tu Ying and Zhu Lin, Lipids and Their Derivatives: By-Products Used as Essential Building Blocks for Modern Drug Delivery Systems, Current Drug Targets 2014; 15 (5) . https://dx.doi.org/10.2174/1389450115666140306154120
DOI https://dx.doi.org/10.2174/1389450115666140306154120 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Recent Advancements in Nanodiamond Mediated Brain Targeted Drug
Delivery and Bioimaging of Brain Ailments: A Holistic Review
Pharmaceutical Nanotechnology Gene Therapy Targeting in the Central Nervous System
Current Gene Therapy Antiretroviral and Antituberculosis Therapy in HIV-TB Co-Infected Children
Current Pediatric Reviews The Role of Vasopressin in Affective Disorders: Possible Targets of Intervention
Central Nervous System Agents in Medicinal Chemistry The Role of Protease-Activated Receptors for the Development of Myocarditis: Possible Therapeutic Implications
Current Pharmaceutical Design The Role of CD8+ T Cells in Multiple Sclerosis and its Animal Models
Current Drug Targets - Inflammation & Allergy The Mechanism by which the Phenothiazine Thioridazine Contributes to Cure Problematic Drug-Resistant Forms of Pulmonary Tuberculosis: Recent Patents for “New Use”
Recent Patents on Anti-Infective Drug Discovery Sepsis and Solid Organ Transplantation
Current Drug Targets The Antibiotic Potential of Prokaryotic IMP Dehydrogenase Inhibitors
Current Medicinal Chemistry Structure, Biological Properties and Applications of Marine-derived Polysaccharides
Current Organic Chemistry DNA Methylation in the Pathogenesis of Systemic Lupus Erythematosus
Current Pharmacogenomics Is there a Role for Bevacizumab in Non-Glial Tumors?
Current Drug Targets Magnetite Nanoshuttles for Fighting Staphylococcus aureus Infections: A Recent Review
Current Topics in Medicinal Chemistry Benzopyran Derivatives as Cardio-selective ATP-sensitive Potassium Channel Openers: A Review
Mini-Reviews in Medicinal Chemistry Drug Target in Eosinophilic Meningitis Caused by Angiostrongylus cantonensis
Infectious Disorders - Drug Targets Adolescents Attitudes Toward Vaccinations: A Systematic Review
Current Pediatric Reviews Opportunities and Challenges for Host-Directed Therapies in Tuberculosis
Current Pharmaceutical Design Aquaporins and Glia
Current Neuropharmacology Nanowired Drug Delivery of Antioxidant Compound H-290/51 Enhances Neuroprotection in Hyperthermia-Induced Neurotoxicity
CNS & Neurological Disorders - Drug Targets Advances in Adjuvant Therapy Against Acute Bacterial Meningitis
Current Drug Targets - Infectious Disorders